Copyright
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Oncol. Apr 24, 2024; 15(4): 482-495
Published online Apr 24, 2024. doi: 10.5306/wjco.v15.i4.482
Published online Apr 24, 2024. doi: 10.5306/wjco.v15.i4.482
Focus on current and emerging treatment options for glioma: A comprehensive review
Brandon Lucke-Wold, Department of Neurosurgery, University of Florida, Gainesville, FL 32608, United States
Burhanuddin Sohail Rangwala, Muhammad Ashir Shafique, Mohammad Arham Siddiq, Muhammad Saqlain Mustafa, Fnu Danish, Rana Muhammad Umer Nasrullah, Abdul Haseeb, Department of Neurosurgery, Jinnah Sindh Medical University, Karachi 75510, Pakistan
Noor Zainab, Department of Neurosurgery, Army Medical College, Rawalpindi 46000, Pakistan
Author contributions: Shafique MA and Lucke-Wold B conceptualized the study; Danish F and Mustafa MS conducted a literature search; Drafting of the manuscript and writing was done by Nasrullah RMU, Rangwala BS, Siddiq MA, Zainab N and AH performed the editing; All authors read and agreed to the final version of the manuscript; All the authors have revised the manuscript accordingly.
Conflict-of-interest statement: All authors have no conflicts of interest to disclose.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Muhammad Ashir Shafique, MBBS, Doctor, Researcher, Department of Neurosurgery, Jinnah Sindh Medical University, Haji Rafique Road Karachi Sindh, Karachi 75510, Pakistan. ashirshafique109@gmail.com
Received: November 22, 2023
Peer-review started: November 22, 2023
First decision: January 12, 2024
Revised: January 22, 2024
Accepted: February 28, 2024
Article in press: February 28, 2024
Published online: April 24, 2024
Processing time: 147 Days and 18.4 Hours
Peer-review started: November 22, 2023
First decision: January 12, 2024
Revised: January 22, 2024
Accepted: February 28, 2024
Article in press: February 28, 2024
Published online: April 24, 2024
Processing time: 147 Days and 18.4 Hours
Core Tip
Core Tip: Our manuscript explores the dynamic landscape of glioma treatment, emphasizing the urgent need for innovative therapies to combat this prevalent central nervous system malignancy. We delve into the promising realm of immunotherapies, highlighting novel agents like zotiraciclib, pembrolizumab, and lerapolturev, offering insights into their mecha